Skip to main content
. 2007 Jan 12;3:2. doi: 10.1186/1745-9974-3-2

Table 2.

Pulmonary function on beraprost and placebo treatments in patients with bronchial asthma

Run-in Placebo Washout Beraprost
FVC as % pred. (%) 96.8 ± 5.7 103.4 ± 3.3 104.4 ± 3.1 103.4 ± 3.4
FEV1 as% pred. (%) 90.9 ± 5.7 94.1 ± 5.5 93.0 ± 5.6 93.2 ± 5.6
MMF as% pred. (%) 50.7 ± 6.7 52.0 ± 6.0 50.1 ± 6.4 51.5 ± 6.4

Data are shown as standard error of the mean for FVC, FEV1 and MMF.

* p < 0.05 compared with each control value (Wilcoxon signed-ranks test).